No abstract available
Publication types
-
Comparative Study
-
Consensus Development Conference
-
Review
MeSH terms
-
Amantadine / administration & dosage
-
Amantadine / therapeutic use
-
Animals
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / therapeutic use
-
Carcinoma, Hepatocellular / etiology
-
Carcinoma, Hepatocellular / prevention & control
-
Drug Therapy, Combination
-
Ethanol / adverse effects
-
Follow-Up Studies
-
Hepatitis C, Chronic / complications
-
Hepatitis C, Chronic / diagnosis
-
Hepatitis C, Chronic / drug therapy*
-
Hepatitis C, Chronic / virology
-
Humans
-
Interferons / administration & dosage
-
Interferons / adverse effects
-
Interferons / therapeutic use
-
Liver Cirrhosis / etiology
-
Liver Neoplasms / etiology
-
Liver Neoplasms / prevention & control
-
Mice
-
Mice, Transgenic
-
Multicenter Studies as Topic
-
Obesity / complications
-
Randomized Controlled Trials as Topic
-
Recurrence
-
Ribavirin / administration & dosage
-
Ribavirin / adverse effects
-
Ribavirin / therapeutic use
-
Risk Factors
-
Smoking / adverse effects
-
Time Factors
Substances
-
Antiviral Agents
-
Ethanol
-
Ribavirin
-
Interferons
-
Amantadine